These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 34645604

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drug-induced nail disorders: incidence, management and prognosis.
    Piraccini BM, Tosti A.
    Drug Saf; 1999 Sep; 21(3):187-201. PubMed ID: 10487397
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
    Roh MR, Cho JY, Lew W.
    Yonsei Med J; 2007 Feb 28; 48(1):124-6. PubMed ID: 17326255
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mitoxantrone-induced discoloration of the nails.
    Scheithauer W, Ludwig H, Kotz R, Depisch D.
    Eur J Cancer Clin Oncol; 1989 Apr 28; 25(4):763-5. PubMed ID: 2714352
    [No Abstract] [Full Text] [Related]

  • 28. Diseases of the generative nail apparatus. Part II: nail bed.
    Goodman GJ, Nicolopoulos J, Howard A.
    Australas J Dermatol; 2002 Aug 28; 43(3):157-68; quiz 169-70. PubMed ID: 12121391
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Onycholysis associated with Kawasaki disease: A comment on "Characteristic nail lesions in Kawasaki disease: Case series and literature review".
    Otani A, Iio K, Hataya H.
    J Dermatol; 2022 Aug 28; 49(8):e291-e292. PubMed ID: 35307858
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cyclophosphamide-induced melanonychia in a patient with steroid dependent nephrotic syndrome: A rare presentation.
    Mehta S, Makkar V, Soha PM, Sethi S, Kaur S.
    Saudi J Kidney Dis Transpl; 2019 Aug 28; 30(4):978-981. PubMed ID: 31464259
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Discoloration of the nails and early anemia after mitoxantrone, folinic acid and 5-fluorouracil.
    Seminara P, Franchi F, Codacci-Pisanelli G, Aronne T, Abdolrahim zadeh S.
    Med Oncol Tumor Pharmacother; 1990 Aug 28; 7(4):291-2. PubMed ID: 2283895
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An annoying mass of the nail bed.
    Dika E, Chessa MA, Fanti PA, Alessandrini A, Starace M, Piraccini BM.
    Indian J Dermatol Venereol Leprol; 2018 Aug 28; 84(2):244-246. PubMed ID: 28836509
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.